When symptoms appear and go away unpredictably during the week, its easy to think they arent related to the medication
15 minutes for routine follow-ups
We do not know whether the insulin-sensitizing effects of GLP-1/GIP agonism adequately counterbalance the insulin-desensitizing effects of GH elevation when both occur simultaneously
After 72 weeks of treatment: 5 mg dose: 15.0% mean body weight reduction 10 mg dose: 19.5% mean body weight reduction 15 mg dose: 20.9% mean body weight reduction Placebo: 3.1% mean body weight reduction Among participants receiving 15 mg, approximately 57% achieved at least 20% weight loss
The Obesity Medicine Association, the largest organization of clinicians dedicated to preventing, treating, and reversing the disease of obesity, co-authored the 2025 joint advisory on Nutritional Priorities to Support GLP-1 Therapy, identifying adequate protein intake, lean mass preservation, and resistance training as the three most critical nutritional priorities for patients receiving GLP-1 receptor agonists for obesity care
Our comprehensive support system ensures that patients not only achieve their weight loss objectives but also maintain them over the long term, fostering a healthier lifestyle